Skip to main content
SpringerLink
Log in

Osteoporose – aktuelle Diagnostik und Therapie

Osteoporosis – Current Diagnostics and Therapy

  • Praxis
  • Published:
Medizinische Klinik Aims and scope Submit manuscript

Zusammenfassung

Osteoporotische Knochenbrüche sind eine häufige Ursache von Einbußen an Selbstständigkeit und Lebensqualität im Alter. Der Erhalt von Muskulatur und Koordination, die tägliche Zufuhr von 1 000 mg Calcium, eine ausreichende Versorgung mit Vitamin D und ein umsichtiger Umgang mit sturz- bzw. osteoporosefördernden Medikamenten sind die wichtigsten Basismaßnahmen zur Frakturvermeidung. Ab einem 10-Jahres-Frakturrisiko von 30% für proximale Femurfrakturen und Wirbelkörperfrakturen empfiehlt die Leitlinie des Dachverbands Osteologie eine Langzeittherapie mit spezifischen Osteoporosemedikamenten.

Abstract

Osteoporotic fractures are a frequent cause of disability and a loss of quality of life in old age. Maintenance of muscle function and balance, a daily calcium intake of 1,000 mg, sufficient vitamin D, and a prudent use of fall- and osteoporosis-associated drugs are key components of fracture prevention. The German guideline recommends to initiate a specific long-term osteoporosis medication in individuals with a 30% 10-year risk for hip fractures and vertebral fractures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bauer DC, Ettinger B, Nevitt MC, et al. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 2001;134:561–8.

    PubMed  CAS  Google Scholar 

  2. Bianchi G, Sambrook P. Oral nitrogen-containing bisphosphonates: a systematic review of randomized clinical trials and vertebral fractures. Curr Med Res Opin 2008;24:2669–77.

    Article  PubMed  CAS  Google Scholar 

  3. Blake GM, Fogelman I. Role of dual-energy x-ray absorptiometry in the diagnosis and treatment of osteoporosis. J Clin Densitom 2007;10:102–10.

    Article  PubMed  Google Scholar 

  4. Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008;336:262–6.

    Article  PubMed  CAS  Google Scholar 

  5. Consensus Development Conference. Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646–6.

    Article  Google Scholar 

  6. Curtis JR, Westfall AO, Cheng H, et al. Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday. Osteoporos Int 2008;19:1613–20.

    Article  PubMed  CAS  Google Scholar 

  7. DVO, Hrsg. Osteoporose-Leitlinie: Prophylaxe, Diagnostik und Therapie — bei Frauen ab der Menopause, bei Männern ab dem 60. Lebensjahr. Stuttgart: Schattauer, 2006.

    Google Scholar 

  8. Gallagher A, Rietbrock S, Olson M, et al. Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res 2008;23:1569–75.

    Article  PubMed  Google Scholar 

  9. Hiligsmann M, Ethgen O, Richy F, et al. Utility values associated with osteoporotic fracture: a systematic review of the literature. Calcif Tissue Int 2008;82:288–92.

    Article  PubMed  CAS  Google Scholar 

  10. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S–6S.

    PubMed  CAS  Google Scholar 

  11. Ito Z, Harada A, Matsui Y, et al. Can you diagnose for vertebral fracture correctly by plain X-ray? Osteoporos Int 2006;17:1584–91.

    Article  PubMed  CAS  Google Scholar 

  12. Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004;35:375–82.

    Article  PubMed  CAS  Google Scholar 

  13. McCloskey EV, Johansson H, Oden A, et al. Ten-year fracture probability identifies women who will benefit from clodronate therapy - additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int 2009:20:811–7.

    Article  PubMed  CAS  Google Scholar 

  14. Pfeilschifter J. Schmerztherapie bei Osteoporose. Allgemeinarzt 2007;19:32–7.

    Google Scholar 

  15. Saag KG, Shane E, Boonen S, et al. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 2007;357:2028–39.

    Article  PubMed  CAS  Google Scholar 

  16. Seeman E. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy? Bone 2007;41:308–17.

    Article  PubMed  CAS  Google Scholar 

  17. Steingrimsdottir L, Gunnarsson O, Indridason OS, et al. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005;294:2336–41.

    Article  PubMed  CAS  Google Scholar 

  18. Tervo T, Nordström P, Neovius M, et al. Constant adaptation of bone to current physical activity level in men: a 12-year longitudinal study. J Clin Endocrinol Metab 2008;93:4873–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin III, Alfried Krupp Krankenhaus – Steele, Essen, Germany

    Johannes Pfeilschifter

  2. Klinik für Innere Medizin III, Alfried Krupp Krankenhaus – Steele, Hellweg 100, 45276, Essen, Germany

    Johannes Pfeilschifter

Authors
  1. Johannes Pfeilschifter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Johannes Pfeilschifter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfeilschifter, J. Osteoporose – aktuelle Diagnostik und Therapie. Med Klin 104, 632–643 (2009). https://doi.org/10.1007/s00063-009-1135-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-009-1135-2

Schlüsselwörter:

Key Words:

Search

Navigation